|
|
||||||||

,
*
Trudeau Institute, Saranac Lake, NY 12983;
Department of Immunology, St. Jude Childrens Research Hospital, Memphis, TN 38105; and
Department of Pathology, University of Tennessee, Memphis, TN 38163
Current vaccines designed to promote humoral immunity to respiratory virus infections also induce potent CD4+ T cell memory. However, little is known about the impact of primed CD4+ T cells on the immune response to heterologous viruses that are serologically distinct, but that share CD4+ T cell epitopes. In addition, the protective capacity of primed CD4+ T cells has not been fully evaluated. In the present study, we addressed these two issues using a murine Sendai virus model. Mice were primed with an HN421436 peptide that represents the dominant CD4+ T cell epitope on the hemagglutinin-neuraminidase (HN) of Sendai virus. This vaccination strategy induced strong CD4+ T cell memory to the peptide, but did not induce Abs specific for the Sendai virus virion. Subsequent Sendai virus infection of primed mice resulted in 1) a substantially accelerated virus-specific CD4+ T cell response in the pneumonic lung; 2) enhanced primary antiviral Ab-forming cell response in the mediastinal lymph nodes; and 3) accelerated viral clearance. Interestingly, the virus-specific CD8+ T cell response in the lung and the development of long-term memory CD8+ T cells in the spleen were significantly reduced. Taken together, our data demonstrate that primed CD4+ T cells, in the absence of pre-existing Ab, can have a significant effect on the subsequent immune responses to a respiratory virus infection.
This article has been cited by other articles:
![]() |
A. M. Davis, K. A. Hagan, L. A. Matthews, G. Bajwa, M. A. Gill, M. Gale Jr., and J. D. Farrar Blockade of Virus Infection by Human CD4+ T Cells via a Cytokine Relay Network J. Immunol., May 15, 2008; 180(10): 6923 - 6932. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Richards, F. A. Chaves, F. R. Krafcik, D. J. Topham, C. A. Lazarski, and A. J. Sant Direct Ex Vivo Analyses of HLA-DR1 Transgenic Mice Reveal an Exceptionally Broad Pattern of Immunodominance in the Primary HLA-DR1-Restricted CD4 T-Cell Response to Influenza Virus Hemagglutinin J. Virol., July 15, 2007; 81(14): 7608 - 7619. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Smiley, M. M. McNeal, M. Basu, A. H.-C. Choi, J. D. Clements, and R. L. Ward Association of Gamma Interferon and Interleukin-17 Production in Intestinal CD4+ T Cells with Protection against Rotavirus Shedding in Mice Intranasally Immunized with VP6 and the Adjuvant LT(R192G) J. Virol., April 15, 2007; 81(8): 3740 - 3748. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Whitmire, N. Benning, and J. L. Whitton Precursor Frequency, Nonlinear Proliferation, and Functional Maturation of Virus-Specific CD4+ T Cells. J. Immunol., March 1, 2006; 176(5): 3028 - 3036. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Stober, I. Jomantaite, R. Schirmbeck, and J. Reimann NKT Cells Provide Help for Dendritic Cell-Dependent Priming of MHC Class I-Restricted CD8+ T Cells In Vivo J. Immunol., March 1, 2003; 170(5): 2540 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Winslow, A. D. Roberts, M. A. Blackman, and D. L. Woodland Persistence and Turnover of Antigen-Specific CD4 T Cells During Chronic Tuberculosis Infection in the Mouse J. Immunol., February 15, 2003; 170(4): 2046 - 2052. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Cauley, T. Cookenham, T. B. Miller, P. S. Adams, K. M. Vignali, D. A. A. Vignali, and D. L. Woodland Cutting Edge: Virus-Specific CD4+ Memory T Cells in Nonlymphoid Tissues Express a Highly Activated Phenotype J. Immunol., December 15, 2002; 169(12): 6655 - 6658. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Wolkers, M. Toebes, M. Okabe, J. B. A. G. Haanen, and T. N. M. Schumacher Optimizing the Efficacy of Epitope-Directed DNA Vaccination J. Immunol., May 15, 2002; 168(10): 4998 - 5004. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. McNeal, J. L. VanCott, A. H. C. Choi, M. Basu, J. A. Flint, S. C. Stone, J. D. Clements, and R. L. Ward CD4 T Cells Are the Only Lymphocytes Needed To Protect Mice against Rotavirus Shedding after Intranasal Immunization with a Chimeric VP6 Protein and the Adjuvant LT(R192G) J. Virol., January 15, 2002; 76(2): 560 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhong, A. D. Roberts, and D. L. Woodland Antibody-Independent Antiviral Function of Memory CD4+ T Cells In Vivo Requires Regulatory Signals from CD8+ Effector T Cells J. Immunol., August 1, 2001; 167(3): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hogan, W. Zhong, E. J. Usherwood, T. Cookenham, A. D. Roberts, and D. L. Woodland Protection from Respiratory Virus Infections Can Be Mediated by Antigen-Specific Cd4+ T Cells That Persist in the Lungs J. Exp. Med., April 16, 2001; 193(8): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hogan, E. J. Usherwood, W. Zhong, A. D. Roberts, R. W. Dutton, A. G. Harmsen, and D. L. Woodland Activated Antigen-Specific CD8+ T Cells Persist in the Lungs Following Recovery from Respiratory Virus Infections J. Immunol., February 1, 2001; 166(3): 1813 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. ONeill, S. L. Krauss, J. M. Riberdy, R. G. Webster, and D. L. Woodland Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice J. Gen. Virol., November 1, 2000; 81(11): 2689 - 2696. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |